Dr. Peter Robins Watson, MD

  • Greenville, NC
  • Medical oncologist
NPI1376528687PAC ID1355422395
Medicare services, 2024
146
Medicare patients, 2024
51
Part D claims, 2024
108
Publications
3
Clinical trials
10
Practice address
2100 Stantonsburg Rd, Greenville, NC 27834
Practice phone
Call (252) 847-4100
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

ECU Health Medical Center

Hospital · Greenville, North Carolina

See all 7 affiliations

Find Dr. Watson's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Peter Robins Watson is a medical oncologist in Greenville, North Carolina

Dr. Watson practices at ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina.

Dr. Watson's NPI, 1376528687, was assigned on December 8, 2005. Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983. Dr. Watson holds North Carolina license 28446.

NPI and contact details
Medicare PAC ID
1355422395
NPI enumeration date
December 8, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(252) 847-4100
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
69
Medical school graduation
1983

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Peter Robins Watson practices at ECU Health Medical Center in Greenville, North Carolina

Dr. Watson's primary practice is ECU Health Medical Center, at 2100 Stantonsburg Rd, Greenville, NC 27834 in Pitt County. The practice phone is (252) 847-4100.

Source: Dmand AI Affiliation Data

Dr. Peter Robins Watson is affiliated with 3 sites of care and 4 medical groups

Dr. Watson's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. The medical group on file is ECU Health. Dmand AI also links Dr. Watson to 3 more medical groups and 2 group practices and clinics, each named with a free account.

See all 7 affiliations for Dr. Watson

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Peter Robins Watson's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Watson practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
ECU Health Medical CenterAvailable with a free account
+2 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Watson practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University Health Systems of Eastern Carolina and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Peter Robins Watson is one of 203 medical oncologists in North Carolina

Medical oncology is Dr. Watson's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Watson is licensed in North Carolina.

Specialties and state licenses

  • Medical oncology, North CarolinaPrimaryLicense 28446 · taxonomy 207RX0202X

Medical oncologists near Dr. Watson

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

203medical oncologists in North Carolina
2medical oncologists in Greenville

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Peter Robins Watson billed Medicare for 146 services in 2024

CMS data shows 146 Medicare services from Dr. Watson across 6 procedure codes in 2024, for 51 Medicare patients. Medicare paid $6,031 for them. Every service was in an office.

Medicare services, 2024146
Medicare patients51
Paid by Medicare$6,031
Procedure codes6

Dr. Watson's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Lab and pathology
2023: 2,4552024: 6297%
Other services
2023: 5682024: 3594%
Office and hospital visits
2023: 8482024: 2797%
Surgery
2023: 1742024: 2287%
Drugs given in the office
2023: 36,7222024: 0100%
Imaging
2023: 922024: 0100%
Tests and treatments
2023: 1,2222024: 0100%

Dr. Watson compared with the North Carolina median for medical oncologists, 2024

  • Dr. Watson
  • North Carolina median
Medicare services
146vs 52572% below
Medicare patients
51vs 16669% below
Part D claims
35vs 36790% below

Medians across 199 medical oncologists in North Carolina with Dmand AI profiles that report each measure.

Dr. Watson's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Watson

Need commercial claims for Dr. Watson?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Watson and other medical oncologists in North Carolina.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Peter Robins Watson treated 51 Medicare patients in 2024, average age 76

CMS counts 51 Medicare patients who saw Dr. Watson in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.15, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Watson's median patient age at 74, with 58% women.

Medicare patients, 202451
Average age76
Average risk score2.15

Dr. Watson's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Watson's Medicare patients by sex, 2024

  • Women2243%
  • Men2957%

Chronic conditions among Dr. Watson's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer67%
  4. Ischemic heart disease65%
  5. Arthritis47%
  6. COPD39%
  7. Diabetes39%
  8. Heart failure33%

Share of Medicare patients with each condition. A patient can have several.

Dr. Watson's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women58%
  • Men42%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Peter Robins Watson wrote 108 Medicare Part D claims in 2024

In 2024, Dr. Watson wrote 108 Medicare Part D claims for 37 patients. 81% of them were for generic drugs. CMS names the drug for 35 of them, across 3 drugs with 11 or more claims each, at $8,068 in total drug cost. In 2023, CMS named 560 claims across 22 drugs.

Part D claims, 2024108
Drugs named by CMS3
Total drug cost$8,068
Part D patients37

Dr. Watson's Part D claims by kind of drug, 2024

  • Generic88 claims81%
  • Brand-name20 claims19%

Dr. Watson's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5602024: 3594%

Drugs named by CMS: 3 in 2024, 22 in 2023.

See all prescribing by Dr. Watson

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Peter Robins Watson scored 97 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Watson for performance year 2024, reported through an alternative payment model (APM). Dr. Watson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Watson's MIPS scores, performance year 2024

  • 97of 100Final score
  • 82.4of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Watson by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Peter Robins Watson has 3 publications on record

Dmand AI links 3 papers to Dr. Watson, published from 2015 to 2020. Dr. Watson's most frequent co-authors are James Norman Atkins, MD, Monica Marie Bertagnolli, MD and Philip J. Bierman, MD.

Papers3
Years published2015 to 2020

Dr. Watson's papers by year, 2015 to 2020

Dr. Watson's most frequent co-authors

Recent publications by Dr. Watson

See all 3 publications and co-authors

See who Dr. Watson researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Watson works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Peter Robins Watson has worked on 10 clinical trials

Dmand AI links Dr. Watson to 10 clinical trials, 5 of them phase 3 studies. 9 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Breast Carcinoma In Situ. National Cancer Institute (NCI) sponsors the most, 8.

Clinical trials with Dr. Watson by phase

  1. NonePhase 1: no trials
  2. 1Phase 1/2: 1 trial
  3. 3Phase 2: 3 trials
  4. 1Phase 2/3: 1 trial
  5. 5Phase 3: 5 trials
  6. NonePhase 4: no trials

Conditions in Dr. Watson's trials

  • Melanoma
  • Nevi and Melanomas
  • Breast Carcinoma In Situ
  • Breast Neoplasms
  • Burkitt Lymphoma

Investigators on the most trials with Dr. Watson

Recent clinical trials with Dr. Watson

See all 10 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Peter Robins Watson received $7,208 in industry payments from 2016 to 2025

CMS Open Payments shows 516 general payments to Dr. Watson from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 91% of the total. Genentech, Inc. paid the most, $787.

General payments to Dr. Watson by program year, 2016 to 2025

General payments to Dr. Watson by kind, 2016 to 2025

$7.2Kin total
  • Food and beverage$6,56991%
  • Education$6399%

Companies that paid Dr. Watson the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Watson

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Peter Robins Watson graduated from University of North Carolina at Chapel Hill School of Medicine

Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983.

  1. Medical schoolUniversity of North Carolina at Chapel Hill School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Peter Robins Watson's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Peter Robins Watson

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Peter Robins Watson's NPI number?

Dr. Peter Robins Watson's NPI number is 1376528687. It was assigned on December 8, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Peter Robins Watson?

Dr. Peter Robins Watson is a medical oncologist in Greenville, North Carolina. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Peter Robins Watson practice?

Dr. Watson practices at 2100 Stantonsburg Rd, Greenville, NC 27834. Dr. Watson's primary practice is ECU Health Medical Center in Greenville, North Carolina, part of University Health Systems of Eastern Carolina. Dmand AI also links Dr. Watson to 3 medical groups and 2 group practices and clinics.

What is Dr. Peter Robins Watson's office phone number?

The practice phone on file for Dr. Watson is (252) 847-4100.

What is Dr. Peter Robins Watson's medical license number?

Dr. Watson holds North Carolina license 28446.

Which hospitals is Dr. Peter Robins Watson affiliated with?

Dr. Watson practices at ECU Health Medical Center in Greenville, North Carolina.

What medical group is Dr. Peter Robins Watson part of?

Dr. Watson is linked to ECU Health. Dmand AI links Dr. Watson to 3 more medical groups.

Does Dr. Peter Robins Watson accept Medicare?

Yes. CMS data shows Dr. Watson billed Medicare for 146 services in 2024, and Dr. Watson accepts Medicare assignment.

What is Dr. Peter Robins Watson's MIPS score?

Dr. Watson's MIPS final score for performance year 2024 is 97 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Peter Robins Watson see?

CMS counts 51 Medicare patients who saw Dr. Watson in 2024, with an average age of 76.

Show 7 more questionsShow fewer questions

What services does Dr. Peter Robins Watson bill to Medicare?

In 2024, Dr. Watson's most billed Medicare services were quality measure (M0010), office visit, established patient (99214) and lab and pathology test (80053).

Where did Dr. Peter Robins Watson go to medical school?

Dr. Watson graduated from University of North Carolina at Chapel Hill School of Medicine in 1983.

What drugs does Dr. Peter Robins Watson prescribe most?

In 2024 Medicare Part D data, Dr. Watson's most prescribed drugs by claims were Tamoxifen Citrate, Abiraterone Acetate and Anastrozole.

Has Dr. Peter Robins Watson received payments from drug or device companies?

CMS Open Payments shows $7,208 in general payments to Dr. Watson from 54 companies from 2016 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Peter Robins Watson been practicing?

Dr. Watson graduated from medical school in 1983, 43 years ago.

Does Dr. Peter Robins Watson do research?

Dmand AI links 3 publications to Dr. Watson, published from 2015 to 2020. Dr. Watson has worked on 10 clinical trials.

Who does Dr. Peter Robins Watson publish with?

Dr. Watson's most frequent co-authors are James Norman Atkins, MD (1 shared paper), Monica Marie Bertagnolli, MD (1 shared paper) and Philip J. Bierman, MD (1 shared paper).

Selling to medical oncology practices?

See medical oncologists in North Carolina by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)